What one share of Bio-Rad Laboratories holds
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $96.20 |
|---|---|
| Profit | $8.26 |
| Capex (buildings and equipment) | $5.18 |
| Free cash flow | $13.12 |
| Cash and investments | $19.33 |
| Debt | $30.36 |
| Book value | $268.22 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2008 | $63.84 | $3.24 | — | — | — | $39.49 |
| 2009 | $64.12 | $5.20 | $2.45 | $9.24 | — | $45.97 |
| 2010 | $68.46 | $6.59 | $3.14 | $4.88 | — | $55.55 |
| 2011 | $72.84 | $6.29 | $3.61 | $5.62 | — | $62.21 |
| 2012 | $72.24 | $5.78 | $4.99 | $4.32 | — | $71.23 |
| 2013 | $73.78 | $2.69 | $3.69 | $2.16 | — | $76.50 |
| 2014 | $74.66 | $3.05 | $4.15 | $5.23 | — | $75.62 |
| 2015 | $68.67 | $3.71 | $3.81 | $2.52 | — | $85.14 |
| 2016 | $69.76 | $0.88 | $4.77 | $2.52 | — | $87.61 |
| 2017 | $71.93 | $4.07 | $3.71 | −$0.24 | — | $98.81 |
| 2018 | $75.74 | $12.10 | $4.29 | $5.15 | — | $134.75 |
| 2019 | $76.59 | $58.27 | $3.26 | $11.91 | — | $192.90 |
| 2020 | $84.40 | $126.47 | $3.60 | $15.80 | — | $332.23 |
| 2021 | $96.75 | $140.83 | $4.43 | $17.73 | — | $458.76 |
| 2022 | $94.08 | −$121.79 | $3.79 | $2.74 | — | $322.82 |
| 2023 | $91.45 | −$21.82 | $5.36 | $7.47 | — | $299.26 |
| 2024 | $90.97 | −$65.36 | $5.87 | $10.26 | — | $232.84 |
| 2025 | $94.69 | $27.85 | $5.78 | $13.73 | — | $273.40 |
Common questions about Bio-Rad Laboratories
How much does one share of Bio-Rad Laboratories earn?
Over the last 12 months, each share of Bio-Rad Laboratories earned $8.26 of profit on $96.20 of sales, keeping about 9¢ of every $1 (profit margin).
Does Bio-Rad Laboratories pay a dividend?
Bio-Rad Laboratories didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Bio-Rad Laboratories’s book value per share?
Bio-Rad Laboratories’s book value is $268.22 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Bio-Rad Laboratories have?
Each share of Bio-Rad Laboratories has $19.33 of cash and investments and $30.36 of debt, as of June 30, 2026.
What is Bio-Rad Laboratories’s free cash flow per share?
$13.12 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
How has Bio-Rad Laboratories’s profit per share changed over time?
Profit per share went from $3.24 in 2008 to $27.85 in 2025, growing about 13.5% a year (adjusted for stock splits).
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.